Home/Filings/4/0001437749-24-000427
4//SEC Filing

LACOUS MIRA K 4

Accession 0001437749-24-000427

CIK 0001019034other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:20 PM ET

Size

4.9 KB

Accession

0001437749-24-000427

Insider Transaction Report

Form 4
Period: 2023-12-29
LACOUS MIRA K
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2023-12-29$2.55/sh+139$3541,341 total
Footnotes (2)
  • [F1]Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.Holdings do not include options to purchase 869 shares.

Issuer

BIO KEY INTERNATIONAL INC

CIK 0001019034

Entity typeother

Related Parties

1
  • filerCIK 0001242836

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:20 PM ET
Size
4.9 KB